Cadila Healthcare jumps ahead of press conference

Meanwhile, the S&P BSE Sensex was down 57.99 points, or 0.30%, to 19,552.49.

On BSE, 1.42 lakh shares were traded in the counter as against an average daily volume of 9,196 shares in the past one quarter.

The stock hit a high of Rs 823 and a low of Rs 774.10 so far during the day. The stock had hit a 52-week high of Rs 964 on 12 September 2012. The stock had hit a 52-week low of Rs 705.05 on 4 June 2012.

The stock had underperformed the market over the past one month till 3 June 2013, falling 0.69% compared with the Sensex's 0.18% rise. The scrip had also underperformed the market in past one quarter, rising 0.67% as against Sensex's 3.66% rise.

The large-cap pharmaceutical company has an equity capital of Rs 102.37 crore. Face value per share is Rs 5.

Cadila Healthcare's consolidated net profit surged 54% to Rs 263 crore on 16% growth in gross sales to Rs 1599 crore in Q4 March 2013 over Q4 March 2012.

Cadila Healthcare is a global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products.

Powered by Capital Market - Live News